- Home
- About us
- News
- Club 30
- About us
- News
- IX Naukowy Dzień Doktoranta
- Serdecznie dziękujemy za wsparcie
- KLUB 30 – warsztaty z (auto)prezentacji w dziedzinie medycyny
- KLUB 30 – warsztaty z przygotowania publikacji naukowych z zakresu medycyny (Proper Medical Writing)
- Wsparcie dla Agatki
- Akromegalia – optymalizacja leczenia
- Wsparcie leczenia córeczki naszej koleżanki.
- Authorities
- Regulations
- Contact
- Archives
- Application form
- Science and education
- Membership fee
- Contact
Polish Society of
Endocrinology
Endocrine diseases as causes of secondary hyperlipidemia
30.12.2019
Łukasz Bułdak, Bogdan Marek, Dariusz Kajdaniuk, Agata Urbanek, Szymon Janyga, Aleksandra Bołdys, Marcin Basiak, Mateusz Maligłówka, Bogusław Okopień
Abstract
Cardiovascular diseases are among the leading causes of increased morbidity and mortality in developed and developing countries. One of the most important risk factors responsible for atherosclerosis and subsequent cardiovascular diseases is hyperlipidaemia. Currently, hyperlipidaemias are divided into several clinical entities. The greatest risk is associated with hypercholesterolaemia. As a result, modern guidelines for the treatment and prevention of atherosclerosis focus predominantly on the reduction of LDL-cholesterol. Hypertriglyceridaemia and atherogenic dyslipidaemia, which are responsible for a less significant increase in the cardiovascular risk, are nowadays secondary targets of the treatment.
During the work-up for hyperlipidaemia one of the essential actions is the exclusion of secondary causes of the lipid abnormalities. Those include, among others, endocrine diseases, diabetes, drugs, nephrotic syndrome, and pregnancy. Data regarding the impact of endocrine disease and diabetes on the lipid profile are scattered. In this review, the authors aimed to perform a thorough analysis of the available publications regarding the topic and the preparation of a comprehensive review dealing with the incidence, clinical features, and the therapy of hyperlipidaemias in patients with endocrine disease.
Keywords: hypercholesterolaemia; hypertriglyceridaemia; hyperlipidaemia; endocrine disease; diabetes